Why Is the Interleukin Inhibitors Market Becoming a Key Focus in Global Healthcare Research?
The rising global burden of inflammatory and autoimmune diseases has placed interleukin inhibitors at the forefront of modern biologic therapies. These agents, which target specific cytokines responsible for immune responses, have transformed the management of conditions such as psoriasis, rheumatoid arthritis, inflammatory bowel disease, and asthma. With the market valued at USD 35.16 billion...
0 Comments 0 Shares 639 Views 0 Reviews